MUFG cut its target price for Nipro, reflecting inventory adjustments ahead of the launch of a new dialyzer product in the United States. The market has remained modestly lower.
MUFG has reportedly cut its target price for Nipro.
The cut is viewed as reflecting inventory adjustments ahead of the launch of a new dialyzer product in the United States.
Against this backdrop, the share price reportedly remained modestly lower.